中石油(00857.HK)參建俄羅斯AGPP項目第一列生產線投產
中石油(00857.HK)公布,由中國石油工程建設公司參與建設的阿穆爾天然氣處理廠(AGPP)項目第一列生產線投產。
公司表示,該項目位於俄羅斯遠東區南部與中國交界的阿穆爾州自由城,是俄羅斯遠東地區最大的基礎設施項目之一,也是中俄東線的源頭工程,設計年加工天然氣420億立方米,建設週期為8年,分5期建設,項目全面建成後將成為世界最大的天然氣處理廠之一。
按照合同約定,項目將每年向中國供應380億立方米商品天然氣。目前工程建設公司負責的P2標段五期工程設計工作已基本完成,75台超大件設備全部運抵現場並吊裝就位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.